Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway

Molecular Medicine Reports

Volumn 11, Issue 3, 2015, Pages 1609-1614

  Liu, Bin ^a   Zhou, Wei ^a   Chen, Xiaofeng ^a   Xu, Fengming ^a   Chen, Yinqin ^a   Liu, Jie ^a   Zhang, Qingyu ^a   Bao, Shiting ^a   Chen, Nianping ^a   Li, Mingyi ^a   Zhu, Runzhi ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Dihydromyricetin; NADPH oxidase 4; Reactive oxygen species; Smad3; Transforming growth factor

Indexed keywords

ANTINEOPLASTIC AGENT; DIHYDROMYRICETIN; FLAVONOID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; FLAVONOL DERIVATIVE; NOX4 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNTING; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; DOWN REGULATION; GENE EXPRESSION; LIVER CELL CARCINOMA; MOUSE; MTT ASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOLS; LIVER NEOPLASMS; MICE; MODELS, BIOLOGICAL; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84916631698     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2891     Document Type: Article

References (40)

1. Wu S, Liu B, Zhang Q, et al: Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma hepg2 cells. PLoS One 8: e76886, 2013.
2. Li H, Li Y, Zhang Y, Shi H, Hu W and Zhang Z: Comparison of refluxing, ultrasonic-and microwave-assisted extraction of dihydromyricetin from Ampelopsis grossedentata. J AOAC Int 91: 1278-1283, 2008.
3. Ye J, Guan Y, Zeng S and Liu D: Ampelopsin prevents apoptosis induced by H2O2 in MT-4 lymphocytes. Planta Med 74: 252-257, 2008.
4. Kundaković K, Stanojković T, Milenković M, Grubin J, Juranić Z, Stevanović B and Kova-ević N: Cytotoxic, antioxidant, and antimicrobial activities of Ampelopsis brevipedunculata and Parthenocissus tricuspidata (Vitaceae). Arch Biol Sci 60: 641-647, 2008.
5. Zhou Y, Shu F, Liang X, et al: Ampelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathway. PLoS One 9: e89021, 2014.
6. Kou X, Shen K, An Y, Qi S, Dai WX and Yin Z: Ampelopsin inhibits H2O2 -induced apoptosis by ERK and Akt signaling pathways and up-regulation of heme oxygenase-1. Phytother Res 26: 988-994, 2012.
7. Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L and Yin Z: Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-B signaling pathways. Int Immunopharmacol 12: 278-287, 2012.
8. Jeon SH, Chun W, Choi YJ and Kwon YS: Cytotoxic constituents from the bark of Salix hulteni. Arch Pharm Res 31: 978-982, 2008.
9. Zhou FZ, Zhang XY and Guo Y: Anti-proliferation effect of combining dihydromyricetin and adriamycin on MDA-MB-231 cell in vitro. Journal of Hubei University for Nationalities (Medical Edition) 4: 001, 2010.
10. Guo X, Zhu K, Zhang H and Yao H: Anti-tumor activity of a novel protein obtained from tartary buckwheat. Int J Mol Sci 11: 5201-5211, 2010.
11. Zhang QY, Li R, Zeng GF, et al: Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression. World J Gastroenterol 20: 10082-10093, 2014.
12. Busse A and Keilholz U: Role of TGF in melanoma. Curr Pharm Biotechnol 12: 2165-2175, 2011.
13. Perrot CY, Javelaud D and Mauviel A: Insights into the transforming growth factor signaling pathway in cutaneous melanoma. Ann Dermatol 25: 135-144, 2013.
14. Moustakas A, Souchelnytskyi S and Heldin CH: Smad regulation in TGF-beta signal transduction. J Cell Sci 114 (Pt 24): 4359-4369, 2001.
15. Varelas X, Samavarchi-Tehrani P, Narimatsu M, et al: The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF?-SMAD pathway. Developmental cell 19: 831-844, 2010.
16. Brown DI and Griendling KK: Nox proteins in signal transduction. Free Radic Biol and Med 47: 1239-1253, 2009.
17. Tobar N, Guerrero J, Smith PC and Martínez J: NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration. Br J Cancer 103: 1040-1047, 2010.
18. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA and Leto TL: Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor -dependent manner: a new contributor to HCV-induced oxidative stress. J Virol 83: 12934-12946, 2009.
19. Barnes JL and Gorin Y: Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 79: 944-956, 2011.
20. Liu R-M and Gaston Pravia K: Oxidative stress and glutathione in TGF?-mediated fibrogenesis. Free Radical Biology and Medicine 48: 1-15, 2010.
21. Pike LS, Smift AL, Croteau NJ, Ferrick DA and Wu M: Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta 1807: 726-734, 2011.
22. Kisseleva T and Brenner DA: Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233: 109-122, 2008.
23. Pérez-Gómez E, Del Castillo G, Santibáñez JF, Lopez-Novoa JM, Bernabéu C and Quintanilla M: The role of the TGF coreceptor endoglin in cancer. Scientific World Journal 10: 2367-2384, 2010.
24. Baek HJ, Pishvaian MJ, Tang Y, Kim TH, Yang S, Zouhairi ME, Mendelson J, Shetty K, Kallakury B, Berry DL, et al: Transforming growth factor adaptor, -2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer. Hepatology 53: 1676-1684, 2011.
25. Taatjes DJ: The human Mediator complex: a versatile, genome-wide regulator of transcription. Trends Biochem Sci 35: 315-322, 2010.
26. Moses H and Barcellos-Hoff MH: TGF-beta biology in mammary development and breast cancer. Cold Spring Harbor Perspect Biol 3: a003277, 2011.
27. Wiercinska E, Naber HP, Pardali E, van der Pluijm G, van Dam H and ten Dijke P: The TGF/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res Treat 128: 657-666, 2011.
28. Petersen M, Pardali E, Van Der Horst G, Cheung H, van den Hoogen C, van der Pluijm G and Ten Dijke P: Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Oncogene 29: 1351-1361, 2010.
29. Dzwonek J, Preobrazhenska O, Cazzola S, Conidi A, Schellens A, van Dinther M, Stubbs A, Klippel A, Huylebroeck D, ten Dijke P and Verschueren K: Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells. Mol Cancer Res 7: 1342-1353, 2009.
30. Szatrowski TP and Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991.
31. Bierie B and Moses HL: Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 8: 3319-3327, 2009.
32. Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, Aakre M, Shyr Y and Moses HL: Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest 119: 1571-1582, 2009.
33. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC and Moses HL: Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13: 23-35, 2008.
34. Giannelli G, Mazzocca A, Fransvea E, Lahn M and Antonaci S: Inhibiting TGF signaling in hepatocellular carcinoma. Biochim Biophys Acta 1815: 214-223, 2011.
35. Aon MA, Cortassa S and O'Rourke B: Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 1797: 865-877, 2010.
36. Parga J, Rodríguez-Pallares J, Joglar B, Diaz-Ruiz C, Guerra M and Labandeira-Garcia JL: Effect of inhibitors of NADPH oxidase complex and mitochondrial ATP-sensitive potassium channels on generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Dev Dyn 239: 3247-3259, 2010.
37. Li S, Tabar SS, Malec V, Eul BG, Klepetko W, Weissmann N, Grimminger F, Seeger W, Rose F, and Hänze J: NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid Redox Signal 10: 1687-1698, 2008.
38. Liu RM, Choi J, Wu JH, Gaston Pravia KA, Lewis KM, Brand JD, Mochel NS, Krzywanski DM, Lambeth JD, Hagood JS, et al: Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem 285: 16239-16247, 2010.
39. Liu R-M and Gaston Pravia K: Oxidative stress and glutathione in TGF?-mediated fibrogenesis. Free Radic Biol Med 48: 1-15, 2010.
40. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ and Thannickal VJ: NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081, 2009.